Qube Research & Technologies (QRT)
AMGN icon

Qube Research & Technologies (QRT)’s Amgen AMGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
28,600
-45,800
-62% -$15.7M 0.01% 1267
2026
Q1 		$26.2M Sell
74,400
-55,600
-43% -$19.8M 0.03% 726
2025
Q4 		$42.6M Sell
130,000
-700
-0.5% -$222K 0.04% 571
2025
Q3 		$36.9M Buy
130,700
+79,500
+155% +$23.1M 0.04% 609
2025
Q2 		$14.3M Sell
51,200
-9,500
-16% -$2.69M 0.01% 1079
2025
Q1 		$18.9M Sell
60,700
-58,700
-49% -$17.3M 0.02% 774
2024
Q4 		$31.1M Buy
119,400
+36,200
+44% +$10.7M 0.04% 535
2024
Q3 		$26.8M Buy
83,200
+62,200
+296% +$20.3M 0.04% 547
2024
Q2 		$6.56M Sell
21,000
-7,400
-26% -$2.17M 0.01% 1132
2024
Q1 		$8.07M Sell
28,400
-1,300
-4% -$380K 0.01% 962
2023
Q4 		$8.55M Buy
29,700
+27,100
+1,042% +$7.38M 0.02% 796
2023
Q3 		$699K Buy
+2,600
New +$649K ﹤0.01% 1887

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AMGN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Amgen (AMGN) in Q2 2026, closing a stake of 147,488 shares — an estimated $50.5M sold.

Qube Research & Technologies (QRT) first reported a position in AMGN in Q1 2018 and held it in 27 quarters. The position peaked at $333M in Q4 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 147,488 Amgen shares in Q2 2026, an estimated $50.5M.
  • Qube Research & Technologies (QRT) first reported a position in Amgen in Q1 2018 and held it in 27 quarters.
  • Qube Research & Technologies (QRT)'s Amgen position peaked at $333M in Q4 2024.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.